GHP’s capital markets day well-attended
GHP Specialty Care AB (publ) (GHP) today held, on 3 September 2015, a capital markets day on the premises of the Royal Swedish Academy of Engineering Sciences in Stockholm.
The company’s CEO, Daniel Öhman, and the CFO, Tobias Linebäck, presented GHP’s business, strategy and financial position, and explained GHP’s role in the Swedish health care service. The financial objectives previously communicated by the company are unchanged. Mattias Häggblom, former life science analyst at Danske Bank, acted as moderator.
The business was described in greater detail by two of GHP’s heads of clinics, Anders Englund from GHP Arrhythmia Center Stockholm and Tycho Tullberg from GHP Stockholm Spine Center. They gave a picture of what treatment needs these clinics’ specialist competence helps to solve, and of the conditions they work under. The quality work and the continual follow-up of the quality of the health care offered were described as a constant guiding star for the clinics’ operations.
In addition, Jan Karlson, Head of Risk and Health, Skandia Liv, described the background to the agreement that Skandia has entered into with GHP regarding Skandia’s insurance customers in Stockholm, which had previously been presented via a press release on 1 June 2015.
“We see these occasions when we can communicate with shareholders and the market as very valuable. With GHP’s outstanding specialist clinics, there are many stories to be told that can give a clearer feeling of how we work and how we contribute to the quality and efficiency of the health care service, where we can also show that the patient is truly the centre of focus. This is important, not least in the light of the debate about privately versus publicly organized health care, which has previously been prevalent in the media,” comments Daniel Öhman.
The video-recorded presentations from the capital markets day will be available at www.ghp.se shortly. These also contain all PowerPoint presentations used during the capital markets day.
3 September 2015
GHP Specialty Care AB (publ)
Queries should be addressed to:
Daniel Öhman, CEO, Tel: +46 708 55 37 07
Tobias Linebäck, CFO and Head of Investor Relations, Tel: +46 708 55 37 19
GHP is an internationally active health care provider that operates specialist clinics in a select number of diagnostic areas through the application of a business model that is unique in the health care industry, where leading doctors become partners and shareholders. Each clinic specialises in a particular patient group, and this leads to increased efficiency and higher quality. This is the cornerstone of GHP’s business philosophy – “Quality through specialisation”. GHP shares are traded on the Small Cap list of Nasdaq Stockholm under the ticker symbol “GHP”.
GHP Specialty Care AB (publ) | Corp. ID No. 556757-1103
Södra Hamngatan 45 | SE-411 06 Gothenburg | Sweden
Tel +46-31 712 53 00 | Fax +46-31 313 13 21 | www.ghp.se
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.